MATSUMOTO SHUNICHIRO
No ORCID on file
· 96 papers in corpus
· active 2005-2010
Frequent coauthors
- OHNUKI KEI 96
- KINOYAMA ISAO 96
- HIRANO MASAAKI 96
- KUSAYAMA TOSHIYUKI 96
- KAWAMINAMI EIJI 96
- OBITSU KAZUYOSHI 80
- HISAMICHI HIROYUKI 16
- YAMAMOTO HIROFUMI 16
- KOIKE TAKANORI 16
- OSODA KAZUHIKO 16
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …